Why is Rossari Biotech falling/rising?

As of 12-Aug, Rossari Biotech Ltd is currently priced at 635.35, reflecting a decrease of 0.5, or 0.08%. The stock has been on a downward trend, having lost 8.95% over the past week and 10.05% over the past month. It has also experienced a consecutive decline for the last five days. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish sentiment. Despite a low debt-to-equity ratio of 0.03 and a return on equity of 11.5, which suggest a solid valuation, the stock has underperformed significantly over the past year with a return of -30.26%. Additionally, there has been a notable decline in investor participation, with delivery volume dropping by 27% against the 5-day average.
In the broader market context, Rossari Biotech's performance has been considerably weaker compared to the benchmark Sensex, which has only declined by 0.59% over the past week. The stock's year-to-date performance shows a stark contrast, with Rossari Biotech down 19.34% while the Sensex has gained 2.68%. This underperformance may be attributed to the high institutional holdings at 21.32%, which could indicate that institutional investors are cautious about the stock's fundamentals. Overall, the combination of declining stock performance, reduced investor participation, and a significant gap between the stock and benchmark returns contributes to the negative sentiment surrounding Rossari Biotech.